Kaseb, A. O. Et Al. 2016. Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma. ONCOTARGET , vol.7, no.43 , 69916-69926.

Kaseb, A. O., Hassan, M., Lacin, S., Abdel-Wahab, R., Amin, H. M., Shalaby, A., ... Wolff, R. A.(2016). Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma. ONCOTARGET , vol.7, no.43, 69916-69926.

Kaseb, Ahmed Et Al. "Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma," ONCOTARGET , vol.7, no.43, 69916-69926, 2016

Kaseb, Ahmed O. Et Al. "Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma." ONCOTARGET , vol.7, no.43, pp.69916-69926, 2016

Kaseb, A. O. Et Al. (2016) . "Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma." ONCOTARGET , vol.7, no.43, pp.69916-69926.

@article{article, author={Ahmed Omar Kaseb Et Al. }, title={Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma}, journal={ONCOTARGET}, year=2016, pages={69916-69926} }